Absci Corp. (ABSI)
8.38
+0.80
(+10.55%)
USD |
NASDAQ |
Nov 18, 10:31
Absci Total Liabilities (Quarterly) : 20.90M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.90M |
| June 30, 2026 | 22.79M |
| March 31, 2026 | 23.62M |
| December 31, 2025 | 26.85M |
| September 30, 2025 | 34.65M |
| June 30, 2025 | 36.52M |
| March 31, 2025 | 33.65M |
| December 31, 2024 | 34.48M |
| September 30, 2024 | 33.90M |
| June 30, 2024 | 34.04M |
| March 31, 2024 | 34.79M |
| December 31, 2023 | 58.30M |
| Date | Value |
|---|---|
| September 30, 2023 | 39.93M |
| June 30, 2023 | 38.75M |
| March 31, 2023 | 41.84M |
| December 31, 2022 | 64.25M |
| September 30, 2022 | 46.44M |
| June 30, 2022 | 50.12M |
| March 31, 2022 | 54.96M |
| December 31, 2021 | 60.09M |
| September 30, 2021 | 61.11M |
| June 30, 2021 | 219.96M |
| March 31, 2021 | 159.96M |
| December 31, 2020 | 21.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 233.79M |
| Moderna, Inc. | 6.631B |
| Tenax Therapeutics, Inc. | 8.355M |
| Exicure, Inc. | 10.42M |
| Recursion Pharmaceuticals, Inc. | 315.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 239.57M |
| Shareholders Equity (Quarterly) | 218.68M |
| Debt to Equity Ratio | 0.015 |
| Current Ratio | 9.644 |
| Net Debt Paydown Yield | 0.04% |